Roche obtains FDA 510(k) Approval for Cobas
Roche’s cobas MRSA/SA Test has received 510(k) approval from the US Food and Drug Administration (FDA) for the early and […]
Say something
Tags: Antibiotic-resistant bacteria, Bacteria, Bacterial diseases, chlamydia/gonorrhea, Cobas, Head, Health/Medical/Pharmaceuticals, healthcare-associated infections, HPV, Infections, Methicillin-resistant Staphylococcus aureus, Microbiology, molecular solution, MRSA/SA infections, overall management, Paul Brown, Roche, Roche Molecular Diagnostics, Staphylococcaceae, Staphylococcus aureus, United States, US Food and Drug Administration
Technology disinfecting food products destroy antibiotic-resistant bacteria
Application of a technology currently used to disinfect food products may help to get around one of the most challenging […]
New program to control tuberculosis by the UN
The United Nations World Health Organization (WHO) and the Stop TB Partnership on 21 July, 2007 launched a US$ 2.15 billion two-year programme to save over 100,000 lives.
MSPC, India launches second phase of drug CD on AIDS, TB
The Drug Information Centre (DIC) of Maharashtra State Pharmacy Council (MSPC), India is planning to launch the second phase of its interactive CD series with drug interaction information on anti ritrovirals (ARVs), anti virals and anti-TB drugs.
Indian Government plans to launch DOTS Plus programme to fight TB
Indian Government is planning top launch Directly-Observed Treatment Short-Course (DOTS) Plus programme to fight with Tuberculosis (TB).
-
-
Flipkart Health+ App Launched
06-04-2022
